CannTrust (NYSE:CTST) Earns “Neutral” Rating from Roth Capital

Roth Capital reiterated their neutral rating on shares of CannTrust (NYSE:CTST) in a research report sent to investors on Tuesday, BenzingaRatingsTable reports.

Other analysts also recently issued research reports about the stock. Citigroup set a $95.00 price objective on shares of iRobot and gave the company a hold rating in a research report on Wednesday, July 3rd. Paradigm Capital reaffirmed a buy rating on shares of CannTrust in a research report on Thursday, May 23rd. Eight Capital downgraded shares of CannTrust from a buy rating to a neutral rating in a research report on Monday. Bank of America reaffirmed a sell rating on shares of Deutsche Bank in a research report on Monday. Finally, Bloom Burton raised shares of CannTrust from an accumulate rating to a buy rating in a research report on Wednesday, May 15th. One investment analyst has rated the stock with a sell rating, three have assigned a hold rating and four have issued a buy rating to the stock. The stock currently has a consensus rating of Hold and a consensus price target of C$7.94.

NYSE CTST opened at C$3.11 on Tuesday. CannTrust has a 12 month low of C$2.69 and a 12 month high of C$11.97. The company’s 50-day moving average is C$5.07. The company has a debt-to-equity ratio of 0.01, a quick ratio of 3.38 and a current ratio of 5.64. The firm has a market cap of $446.26 million, a P/E ratio of -28.27 and a beta of 3.49.

CannTrust (NYSE:CTST) last posted its quarterly earnings data on Tuesday, May 14th. The company reported C$0.09 EPS for the quarter, beating the Zacks’ consensus estimate of C($0.05) by C$0.14. The company had revenue of C$16.85 million during the quarter, compared to the consensus estimate of C$17.00 million. CannTrust had a negative net margin of 22.33% and a negative return on equity of 6.69%. The company’s quarterly revenue was up 114.9% compared to the same quarter last year. During the same quarter in the prior year, the company posted $0.12 EPS. On average, analysts expect that CannTrust will post -0.03 EPS for the current fiscal year.

A number of large investors have recently modified their holdings of CTST. PNC Financial Services Group Inc. purchased a new position in shares of CannTrust during the 1st quarter valued at approximately $26,000. Shell Asset Management Co. purchased a new position in shares of CannTrust during the 1st quarter valued at approximately $41,000. Paragon Capital Management LLC purchased a new position in shares of CannTrust during the 1st quarter valued at approximately $54,000. Winslow Evans & Crocker Inc. purchased a new position in shares of CannTrust during the 1st quarter valued at approximately $56,000. Finally, K.J. Harrison & Partners Inc purchased a new position in shares of CannTrust during the 1st quarter valued at approximately $100,000. 5.96% of the stock is owned by institutional investors.

CannTrust Company Profile

CannTrust Holdings Inc produces and sells medical and recreational cannabis in Canada. It sells dried cannabis and cannabis extracts to the medical patients. CannTrust Holdings Inc was incorporated in 2015 and is headquartered in Vaughan, Canada.

Featured Article: How can investors find ex-dividend dates?

Analyst Recommendations for CannTrust (NYSE:CTST)

Receive News & Ratings for CannTrust Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CannTrust and related companies with MarketBeat.com's FREE daily email newsletter.